HEAL WELL. AGE WELL. LIVE LONGER.(800) 266-7207   ·   contact@clearhealthpass.com
Wound care

The first frontier
is already here.

Rampart™ DL Matrix is the in-market foundation: dehydrated, dual-layer human amniotic membrane for chronic and hard-to-heal wounds.

Rampart™ DL Matrix

The product.
The surrounding record.

Donated placental tissue, recovered with informed consent and supplied in sheet formats. For use in diabetic foot ulcers, venous leg ulcers, arterial and mixed ulcers, pressure injuries, burns, and surgical and traumatic wounds.

FDA-regulated as a Section 361 HCT/P under 21 CFR Part 1271. Not FDA-approved or cleared. Product suitability and use require professional assessment.
Request provider information↗   Full product details↗
At a glance
HCPCSQ4347
TissueDehydrated, dual-layer human amniotic membrane
FormatSheet
Sizes2 × 2, 2 × 3, 2 × 4, 4 × 4, 4 × 6 and 4 × 8 cm
StorageRoom temperature
PlacementNo orientation requirement
UseFor qualified medical professionals only; not for over-the-counter sale
Product statusIn market
DocumentationMeasurement, coverage records and audit workflow

The HCPCS code is listed for provider reference. Coverage is determined by the payer.

Why it matters

Diabetes weighs heaviest
in tribal communities.

13.6%American Indian and Alaska Native adults with diagnosed diabetes (age-adjusted)
10.1%All U.S. adults with diagnosed diabetes (age-adjusted)
4%Patients in the IHS 2024 diabetes care audit with a documented lower-extremity amputation

Wound care is part of that picture.

Source: Indian Health Service, Division of Diabetes Treatment and Prevention, 2024 IHS Diabetes Care and Outcome Audit fact sheet (citing the CDC National Diabetes Statistics Report).

Clinical evidence

Follow the evidence trail.

November 2025

Post-market validation

A study led by Principal Investigator David Burke, MD, MA, was submitted to CMS and all seven Medicare Administrative Contractors.

January 2026

Receipt on the record

CHP reports government-to-government receipt confirmation. Receipt does not establish efficacy, coverage, approval or endorsement.

Read the milestone↗
For clinicians

Get the full context

Request product information, clinical evidence, ordering details and the applicable coverage context directly from the team.

Ask a clinical question↗
Before a graft

Standard care
comes first.

Medicare contractors’ coverage policies for skin substitutes on lower-extremity wounds call for more than four weeks of documented standard wound care before a skin substitute is considered. For venous leg ulcers, that care includes ongoing compression.

The record of that care matters: the platform’s coverage step checks the documented criteria before a claim is made.

Requirements differ by Medicare Administrative Contractor and change over time. This is general information, not a coverage determination. Sources: Novitas LCD L35041 · First Coast LCD L36377

01

Assessment

A full assessment of the wound and the person, including circulation and, for diabetic foot ulcers, blood-sugar management.

02

Debridement

Removing dead or infected tissue from the wound.

03

Pressure and swelling

Offloading pressure for diabetic foot ulcers, or compression for venous leg ulcers.

04

Infection control

Treating and preventing infection in and around the wound.

05

Moisture balance

Managing drainage and keeping the wound bed moist.

06

Smoking

Support to stop smoking.

For facilities

Bring Rampart™ DL Matrix
to your facility.

Clinics, hospitals and tribal and federal health facilities can request product information, ordering details and the coverage documentation that applies to Rampart™ DL Matrix.

Request provider information↗
For patients

Questions
patients ask.

General information, not medical advice. This website does not enroll patients. Ask your healthcare provider about your own care.

What is an amniotic membrane graft?

A thin sheet of tissue from donated placental membrane that a clinician places on a wound as a covering. Rampart™ DL Matrix is a dehydrated, dual-layer amniotic membrane.

How is it applied?

Your clinician cleans the wound, places the graft on the wound bed and covers it with a dressing. They will tell you how to care for the dressing.

Will I need more than one application?

It depends on the wound. Your clinician decides whether more applications are needed.

What if the graft comes off?

Contact your healthcare provider.

What should I watch for?

Contact your healthcare provider promptly if you notice more redness, swelling, pain or drainage at the wound.

Is it covered by insurance?

Coverage depends on your plan, your wound and your medical records. Your provider’s office can tell you what applies to you.

How do I know if it is right for me?

Your healthcare provider decides, usually after other wound care has been tried for several weeks.

In development

What if the graft
could tell you more?

The pipeline explores sensing, protective and regenerative functions. None of these pipeline products is available today.

Development / research

pH-Sense

A graft concept that visually signals wound status without electronics.

Development / research

Anti-biofilm processing

Processing approaches aimed at the biofilm challenge in chronic wounds.

Development / research

Flowable formats

Concepts for deep, tunneling and irregular wounds beyond sheet formats.

Development / research

WoundGuide™

Benchtop work on colorimetric infection detection within the graft.

Development / research

Capture & Active Shield

Research into repair-signal capture and biofilm detection and disruption.

Development / research

Periwound monitoring

Battery-free, phone-read sensing concepts for the area beside the graft.

Coverage and payment depend on current policy, the applicable Medicare Administrative Contractor, medical necessity and case-specific facts. A product code or documentation tool does not guarantee reimbursement.

Bring the conversation to the clinic.

Request product and evidence information from the CHP team.

Start a conversation↗